Hepatitis e

The Lancet

Volumn 379, Issue 9835, 2012, Pages 2477-2488

  Kamar, Nassim ^a,b,c   Bendall, Richard ^d   Legrand Abravanel, Florence ^b,c,e   Xia, Ning Shao ^f   Ijaz, Samreen ^g   Izopet, Jacques ^b,c,e   Dalton, Harry R ^d,h  

^a CHU RANGUEIL   (France)

^b University of Toulouse III   (France)

^c UNIVERSITÉ PAUL SABATIER   (France)

^d ROYAL CORNWALL HOSPITALS NHS TRUST   (United Kingdom)

^e CHU PURPAN   (France)

^f XIAMEN UNIVERSITY   (China)

^g PUBLIC HEALTH ENGLAND   (United Kingdom)

^h PLYMOUTH UNIVERSITY PENINSULA SCHOOLS OF MEDICINE AND DENTISTRY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; CYCLOSPORIN A; HEPATITIS E ANTIBODY; HEPATITIS E VACCINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; RIBAVIRIN; TACROLIMUS; VIRUS RNA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIVIRAL THERAPY; ATAXIA; BLOOD DONOR; BRACHIAL PLEXUS NEUROPATHY; CELLULAR IMMUNITY; CHINA; CHRONICITY; CONFERENCE PAPER; DEVELOPED COUNTRY; DISEASE SEVERITY; DOSE KIDNEY FUNCTION RELATION; DRUG EFFICACY; DRUG SAFETY; ELECTRON MICROSCOPY; ENCEPHALITIS; ENDEMIC DISEASE; FECES ANALYSIS; FOOD INTAKE; GENOTYPE; GERIATRIC PATIENT; GRAFT RECIPIENT; GUILLAIN BARRE SYNDROME; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBLOTTING; IMMUNOSUPPRESSIVE TREATMENT; MATERNAL MORTALITY; MEAT; MIXED INFECTION; MORTALITY; MYOPATHY; NEUROLOGICAL COMPLICATION; NONHUMAN; ORGAN TRANSPLANTATION; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RADICULOPATHY; SEROLOGY; SEROPREVALENCE; SEX DIFFERENCE; THIRD TRIMESTER PREGNANCY; THROMBOCYTOPENIA; TREATMENT CONTRAINDICATION; VIRAL CLEARANCE; VIRUS DETECTION; VIRUS GENOME; VIRUS MORPHOLOGY; VIRUS SHEDDING; VIRUS TRANSMISSION; WATER SUPPLY;

EID: 85101728194     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)61849-7     Document Type: Conference Paper

References (141)

1. Meng XJ, Purcell RH, Halbur PG, et al. A novel virus in swine is closely related to the human hepatitis E virus.Proc Natl Acad Sci USA 1997; 94: 9860-65. (Pubitemid 27408155)
2. Meng XJ. Hepatitis E virus: animal reservoirs and zoonotic risk.Vet Microbiol 2010; 140: 256-65.
3. Payne CJ, Ellis TM, Plant SL, Gregory AR, Wilcox GE. Sequence data suggests big liver and spleen disease virus (BLSV) is genetically related to hepatitis E virus. Vet Microbiol 1999; 68: 119-25. (Pubitemid 29425789)
4. Batts W, Yun S, Hedrick R, Winton J. A novel member of the family Hepeviridae from cutthroat trout (Oncorhynchus clarkii). Virus Res 2011; 158: 116-23.
5. Reyes GR, Purdy MA, Kim JP, et al. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis.Science 1990; 247: 1335-39.
6. Tam AW, Smith MM, Guerra ME, et al. Hepatitis E virus (HEV): molecular cloning and sequencing of the full-length viral genome.Virology 1991; 185: 120-31.
7. Koonin EV, Gorbalenya AE, Purdy MA, Rozanov MN, Reyes GR, Bradley DW. Computer-assisted assignment of functional domains in the nonstructural polyprotein of hepatitis E virus: delineation of an additional group of positive-strand RNA plant and animal viruses. Proc Natl Acad Sci USA 1992; 89: 8259-63.
8. Li TC, Yamakawa Y, Suzuki K, et al. Expression and self-assembly of empty virus-like particles of hepatitis E virus. J Virol 1997; 71: 7207-13. (Pubitemid 27391654)
9. Kalia M, Chandra V, Rahman SA, Sehgal D, Jameel S. Heparan sulfate proteoglycans are required for cellular binding of the hepatitis E virus ORF2 capsid protein and for viral infection. J Virol 2009; 83: 12714-24.
10. Xing L, Wang JC, Li TC, et al. Spatial configuration of hepatitis E virus antigenic domain. J Virol 2011; 85: 1117-24.
11. Yamada K, Takahashi M, Hoshino Y, et al. ORF3 protein of hepatitis E virus is essential for virion release from infected cells.J Gen Virol 2009; 90: 1880-91.
12. Emerson SU, Nguyen HT, Torian U, Burke D, Engle R, Purcell RH. Release of genotype 1 hepatitis E virus from cultured hepatoma and polarized intestinal cells depends on open reading frame 3 protein and requires an intact PXXP motif. J Virol 2010; 84: 9059-69.
13. Guu TS, Liu Z, Ye Q, et al. Structure of the hepatitis E virus-like particle suggests mechanisms for virus assembly and receptor binding. Proc Natl Acad Sci USA 2009; 106: 12992-97.
14. Xing L, Li TC, Mayazaki N, et al. Structure of hepatitis E virion-sized particle reveals an RNA-dependent viral assembly pathway. J Biol Chem 2010; 285: 33175-83.
15. Yamashita T, Mori Y, Miyazaki N, et al. Biological and immunological characteristics of hepatitis E virus-like particles based on the crystal structure. Proc Natl Acad Sci USA 2009; 106: 12986-91.
16. Tang X, Yang C, Gu Y, et al. Structural basis for the neutralization and genotype specificity of hepatitis E virus. Proc Natl Acad Sci USA 2011; 108: 10266-71.
17. Takahashi M, Tanaka T, Takahashi H, et al. Hepatitis E Virus (HEV) strains in serum samples can replicate efficiently in cultured cells despite the coexistence of HEV antibodies: characterization of HEV virions in blood circulation. J Clin Microbiol 2010; 48: 1112-25.
18. Tanaka T, Takahashi M, Kusano E, Okamoto H. Development and evaluation of an efficient cell-culture system for Hepatitis E virus.J Gen Virol 2007; 88: 903-11. (Pubitemid 46359560)
19. Tanaka T, Takahashi M, Takahashi H, et al. Development and characterization of a genotype 4 hepatitis E virus cell culture system using a HE-JF5/15F strain recovered from a fulminant hepatitis patient. J Clin Microbiol 2009; 47: 1906-10.
20. Shukla P, Nguyen HT, Torian U, et al. Cross-species infections of cultured cells by hepatitis E virus and discovery of an infectious virus-host recombinant. Proc Natl Acad Sci USA 2011; 108: 2438-43.
21. Dalton HR, Bendall R, Ijaz S, Banks M. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis 2008; 8: 698-709.
22. Lu L, Li C, Hagedorn CH. Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Rev Med Virol 2006; 16: 5-36. (Pubitemid 43133591)
23. Hakze-van der Honing RW, van Coillie E, Antonis AF, van der Poel WH. First isolation of hepatitis E virus genotype 4 in Europe through swine surveillance in the Netherlands and Belgium. PLoS One 2011; 6: e22673.
24. Tei S, Kitajima N, Takahashi K, Mishiro S. Zoonotic transmission of hepatitis E virus from deer to human beings. Lancet 2003; 362: 371-73. (Pubitemid 36945060)
25. Colson P, Borentain P, Queyriaux B, et al. Pig liver sausage as a source of hepatitis E virus transmission to humans. J Infect Dis 2010; 202: 825-34.
26. Johne R, Plenge-Bönig A, Hess M, Ulrich RG, Reetz J, Schielke A.Detection of a novel hepatitis E-like virus in faeces of wild rats using a nested broad-spectrum RT-PCR. J Gen Virol 2010; 91: 750-58.
27. Takahashi M, Nishizawa T, Sato H, et al. Analysis of the full-length genome of a hepatitis E virus isolate obtained from a wild boar in Japan that is classifiable into a novel genotype. J Gen Virol 2011; 92: 902-08.
28. Zhao C, Ma Z, Harrison TJ, et al. A novel genotype of hepatitis E virus prevalent among farmed rabbits in China. J Med Virol 2009; 81: 1371-79.
29. Legrand-Abravanel F, Mansuy JM, Dubois M, et al. Hepatitis E virus genotype 3 diversity, France. Emerg Infect Dis 2009; 15: 110-14.
30. Purdy MA, Khudyakov YE. Evolutionary history and population dynamics of hepatitis E virus. PLoS One 2010; 5: e14376.
31. Mizuo H, Yazaki Y, Sugawara K, et al. Possible risk factors for the transmission of hepatitis E virus and for the severe form of hepatitis E acquired locally in Hokkaido, Japan. J Med Virol 2005; 76: 341-49. (Pubitemid 40770889)
32. Huang S, Zhang X, Jiang H, et al. Profile of acute infectious markers in sporadic hepatitis E. PLoS One 2010; 5: e13560.
33. Bendall R, Ellis V, Ijaz S, Thurairajah P, Dalton HR. Serological response to hepatitis E virus genotype 3 infection: IgG quantitation, avidity, and IgM response. J Med Virol 2008; 80: 95-101. (Pubitemid 350220094)
34. Engle RE, Yu C, Emerson SU, Meng XJ, Purcell RH. Hepatitis E virus (HEV) capsid antigens derived from viruses of human and swine origin are equally efficient for detecting anti-HEV by enzyme immunoassay. J Clin Microbiol 2002; 40: 4576-80. (Pubitemid 35434950)
35. Emerson SU, Clemente-Casares P, Moiduddin N, Arankalle VA, Torian U, Purcell RH. Putative neutralization epitopes and broad cross-genotype neutralization of Hepatitis E virus confirmed by a quantitative cell-culture assay. J Gen Virol 2006; 87: 697-704.
36. Legrand-Abravanel F, Thevenet I, Mansuy JM, et al. Good performance of immunoglobulin M assays in diagnosing genotype 3 hepatitis E virus infections. Clin Vaccine Immunol 2009; 16: 772-74.
37. Drobeniuc J, Meng J, Reuter G, et al. Serologic assays specific to immunoglobulin M antibodies against hepatitis E virus: pangenotypic evaluation of performances. Clin Infect Dis 2010; 51: e24-27.
38. Herremans M, Bakker J, Duizer E, Vennema H, Koopmans MP.Use of serological assays for diagnosis of hepatitis E virus genotype 1 and 3 infections in a setting of low endemicity.Clin Vaccine Immunol 2007; 14: 562-68.
39. Bendall R, Ellis V, Ijaz S, Ali R, Dalton H. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries.J Med Virol 2010; 82: 799-805.
40. Ghabrah TM, Tsarev S, Yarbough PO, Emerson SU, Strickland GT, Purcell RH. Comparison of tests for antibody to hepatitis E virus.J Med Virol 1998; 55: 134-37. (Pubitemid 28221617)
41. Shrestha MP, Scott RM, Joshi DM, et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med 2007; 356: 895-903. (Pubitemid 46339908)
42. Innis BL, Seriwatana J, Robinson RA, et al. Quantitation of immunoglobulin to hepatitis E virus by enzyme immunoassay.Clin Diagn Lab Immunol 2002; 9: 639-48. (Pubitemid 34538227)
43. Mansuy JM, Peron JM, Bureau C, Alric L, Vinel JP, Izopet J.Immunologically silent autochthonous acute hepatitis E virus infection in France. J Clin Microbiol 2004; 42: 912-13. (Pubitemid 38222697)
44. Mansuy JM, Bendall R, Legrand-Abravanel F, et al. Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis 2011; 17: 2309-12.
45. Baylis SA, Hanschmann KM, Blümel J, Nübling CM, and the HEV Collaborative Study Group. Standardization of hepatitis E virus (HEV) nucleic acid amplification technique-based assays: an initial study to evaluate a panel of HEV strains and investigate laboratory performance. J Clin Microbiol 2011; 49: 1234-39.
46. Chauhan A, Jameel S, Dilawari JB, Chawla YK, Kaur U, Ganguly NK. Hepatitis E virus transmission to a volunteer.Lancet 1993; 341: 149-50. (Pubitemid 23029310)
47. Clayson ET, Myint KS, Snitbhan R, et al. Viremia, fecal shedding, and IgM and IgG responses in patients with hepatitis E. J Infect Dis 1995; 172: 927-33.
48. Dalton HR, Bendall RP, Keane FE, Tedder RS, Ijaz S. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med 2009; 361: 1025-27.
49. Kamar N, Rostaing L, Abravanel F, et al. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis E virus infection. Gastroenterology 2010; 139: 1612-18.
50. Wu T, Zhang J, Su ZJ, et al. Specific cellular immune response in hepatitis E patients. Intervirology 2008; 51: 322-27.
51. Husain MM, Srivastava R, Akondy R, Aggarwal R, Jameel S, Naik S. Evidence of hepatitis E virus exposure among seronegative healthy residents of an endemic area. Intervirology 2011; 54: 139-43.
52. Viswanathan R. Epidemiology. Indian J Med Res 1957; 45 (suppl): 1-29.
53. Zhuang H, Cao XY, Liu CB, Wang GM. Epidemiology of hepatitis E in China. Gastroenterol Jpn 1991; 26 (suppl 3): 135-38.
54. Naik SR, Aggarwal R, Salunke PN, Mehrotra NN. A large waterborne viral hepatitis E epidemic in Kanpur, India. Bull World Health Organ 1992; 70: 597-604.
55. Bile K, Isse A, Mohamud O, et al. Contrasting roles of rivers and wells as sources of drinking water on attack and fatality rates in a hepatitis E epidemic in Somalia. Am J Trop Med Hyg 1994; 51: 466-74. (Pubitemid 24324763)
56. Teshale EH, Howard CM, Grytdal SP, et al. Hepatitis E epidemic, Uganda. Emerg Infect Dis 2010; 16: 126-29.
57. Howard CM, Handzel T, Hill VR, et al. Novel risk factors associated with hepatitis E virus infection in a large outbreak in northern Uganda: results from a case-control study and environmental analysis. Am J Trop Med Hyg 2010; 83: 1170-73.
58. Sharapov MB, Favorov MO, Yashina TL, et al. Acute viral hepatitis morbidity and mortality associated with hepatitis E virus infection: Uzbekistan surveillance data. BMC Infect Dis 2009; 9: 35.
59. Tsega E, Krawczynski K, Hansson BG, Nordenfelt E. Hepatitis E virus infection in pregnancy in Ethiopia. Ethiop Med J 1993; 31: 173-81. (Pubitemid 23252699)
60. Purcell RH, Emerson SU. Hepatitis E: an emerging awareness of an old disease. J Hepatol 2008; 48: 494-503.
61. Aggarwal R, Kumar R, Pal R, Naik S, Semwal SN, Naik SR. Role of travel as a risk factor for hepatitis E virus infection in a disease-endemic area. Indian J Gastroenterol 2002; 21: 14-18.
62. Guthmann JP, Klovstad H, Boccia D, et al. A large outbreak of hepatitis E among a displaced population in Darfur, Sudan, 2004: the role of water treatment methods. Clin Infect Dis 2006; 42: 1685-91. (Pubitemid 43839431)
63. Bryan JP, Iqbal M, Tsarev S, et al. Epidemic of hepatitis E in a military unit in Abbotrabad, Pakistan. Am J Trop Med Hyg 2002; 67: 662-68. (Pubitemid 36014925)
64. Clayson ET, Vaughn DW, Innis BL, Shrestha MP, Pandey R, Malla DB. Association of hepatitis E virus with an outbreak of hepatitis at a military training camp in Nepal. J Med Virol 1998; 54: 178-82. (Pubitemid 28102807)
65. Clayson ET, Shrestha MP, Vaughn DW, et al. Rates of hepatitis E virus infection and disease among adolescents and adults in Kathmandu, Nepal. J Infect Dis 1997; 176: 763-66. (Pubitemid 27360546)
66. Zhang W, He Y, Wang H, et al. Hepatitis E virus genotype diversity in eastern China. Emerg Infect Dis 2010; 16: 1630-32.
67. Zhang S, Wang J, Yuan Q, et al. Clinical characteristics and risk factors of sporadic Hepatitis E in central China. Virol J 2011; 8: 152.
68. Zhu FC, Zhang J, Zhang XF, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 2010; 376: 895-902.
69. Mansuy JM, Peron JM, Abravanel F, et al. Hepatitis E in the south west of France in individuals who have never visited an endemic area. J Med Virol 2004; 74: 419-24. (Pubitemid 39281640)
70. Dalton HR, Stableforth W, Thurairajah P, et al. Autochthonous hepatitis E in Southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease. Eur J Gastroenterol Hepatol 2008; 20: 784-90.
71. Wichmann O, Schimanski S, Koch J, et al. Phylogenetic and case-control study on hepatitis E virus infection in Germany. J Infect Dis 2008; 198: 1732-41.
72. Dalton HR, Fellows HJ, Gane EJ, et al. Hepatitis E in New Zealand. J Gastroenterol Hepatol 2007; 22: 1236-40. (Pubitemid 47222654)
73. Tsang TH, Denison EK, Williams HV, Venczel LV, Ginsberg MM, Vugia DJ. Acute hepatitis E infection acquired in California. Clin Infect Dis 2000; 30: 618-19. (Pubitemid 30205326)
74. Mitsui T, Tsukamoto Y, Hirose A, et al. Distinct changing profiles of hepatitis A and E virus infection among patients with acute hepatitis, patients on maintenance hemodialysis and healthy individuals in Japan. J Med Virol 2006; 78: 1015-24.
75. Kantala T, Maunula L, von Bonsdorff CH, Peltomaa J, Lappalainen M. Hepatitis E virus in patients with unexplained hepatitis in Finland. J Clin Virol 2009; 45: 109-13.
76. Dalton HR, Stableforth W, Hazeldine S, et al. Autochthonous hepatitis E in Southwest England: a comparison with hepatitis A. Eur J Clin Microbiol Infect Dis 2008; 27: 579-85.
77. Kuniholm MH, Purcell RH, McQuillan GM, Engle RE, Wasley A, Nelson KE. Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988-1994. J Infect Dis 2009; 200: 48-56.
78. Faramawi MF, Johnson E, Chen S, Pannala PR. The incidence of hepatitis E virus infection in the general population of the USA. Epidemiol Infect 2011; 139: 1145-50.
79. Boutrouille A, Bakkali-Kassimi L, Cruciere C, Pavio N. Prevalence of anti-hepatitis E virus antibodies in French blood donors. J Clin Microbiol 2007; 45: 2009-10. (Pubitemid 46933947)
80. Bouwknegt M, Engel B, Herremans MM, et al. Bayesian estimation of hepatitis E virus seroprevalence for populations with different exposure levels to swine in The Netherlands. Epidemiol Infect 2008; 136: 567-76. (Pubitemid 351344530)
81. Mansuy JM, Legrand-Abravanel F, Calot JP, et al. High prevalence of anti-hepatitis E virus antibodies in blood donors from South West France. J Med Virol 2008; 80: 289-93.
82. Legrand-Abravanel F, Kamar N, Sandres-Saune K, et al. Hepatitis E virus infection without reactivation in solid-organ transplant recipients, France. Emerg Infect Dis 2011; 17: 30-37.
83. Beale MA, Tettmar K, Szypulska R, Tedder RS, Ijaz S. Is there evidence of recent hepatitis E virus infection in English and North Welsh blood donors? Vox Sang 2011; 100: 340-42.
84. Li RC, Ge SX, Li YP, et al. Seroprevalence of hepatitis E virus infection, rural southern People's Republic of China. Emerg Infect Dis 2006; 12: 1682-88.
85. Kamar N, Weclawiack H, Guilbeaud-Frugier C, et al. Hepatitis E virus and the kidney in solid organ transplant patients. Transplantation 2012; published online Jan 31. DOI:10.1097/TP.0b013e318245f14c.
86. Said B, Ijaz S, Kafatos G, et al, and the Hepatitis E Incident Investigation Team. Hepatitis E outbreak on cruise ship. Emerg Infect Dis 2009; 15: 1738-44.
87. Ijaz S, Vyse AJ, Morgan D, Pebody RG, Tedder RS, Brown D. Indigenous hepatitis E virus infection in England: more common than it seems. J Clin Virol 2009; 44: 272-76.
88. Lockwood GL, Fernandez-Barredo S, Bendall R, Banks M, Ijaz S, Dalton HR. Hepatitis E autochthonous infection in chronic liver disease. Eur J Gastroenterol Hepatol 2008; 20: 800-03.
89. Dalton HR, Bendall RP, Rashid M, et al. Host risk factors and autochthonous hepatitis E infection. Eur J Gastroenterol Hepatol 2011; 23: 1200-05.
90. Dalton HR, Fellows HJ, Stableforth W, et al. The role of hepatitis E virus testing in drug-induced liver injury. Aliment Pharmacol Ther 2007; 26: 1429-35. (Pubitemid 350045603)
91. Davern TJ, Chalasani N, Fontana RJ, et al, and the Drug-Induced Liver Injury Network (DILIN). Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastroenterology 2011; 141: 1665-72, e1-9.
92. Dalton HR, Hazeldine S, Banks M, Ijaz S, Bendall R. Locally acquired hepatitis E in chronic liver disease. Lancet 2007; 369: 1260. (Pubitemid 46566523)
93. Péron JM, Bureau C, Poirson H, et al. Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy. J Viral Hepat 2007; 14: 298-303. (Pubitemid 46587857)
94. Kumar Acharya S, Kumar Sharma P, Singh R, et al. Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death. J Hepatol 2007; 46: 387-94. (Pubitemid 46185699)
95. Nanji AA, French SW. Relationship between pork consumption and cirrhosis. Lancet 1985; 1: 681-83. (Pubitemid 15134829)
96. Dalton HR, Bendall RP, Pritchard C, Henley W, Melzer D. National mortality rates from chronic liver disease and consumption of alcohol and pig meat. Epidemiol Infect 2010; 138: 174-82.
97. Kamar N, Selves J, Mansuy JM, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 2008; 358: 811-17. (Pubitemid 351281642)
98. Gérolami R, Moal V, Colson P. Chronic hepatitis E with cirrhosis in a kidney-transplant recipient. N Engl J Med 2008; 358: 859-60. (Pubitemid 351281667)
99. Haagsma EB, van den Berg AP, Porte RJ, et al. Chronic hepatitis E virus infection in liver transplant recipients. Liver Transpl 2008; 14: 547-53. (Pubitemid 351524412)
100. Gérolami R, Moal V, Picard C, Colson P. Hepatitis E virus as an emerging cause of chronic liver disease in organ transplant recipients. J Hepatol 2009; 50: 622-24.
101. Kamar N, Garrouste C, Haagsma EB, et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 2011; 140: 1481-89.
102. Colson P, Kaba M, Moreau J, Brouqui P. Hepatitis E in an HIV-infected patient. J Clin Virol 2009; 45: 269-71.
103. Kenfak-Foguena A, Schöni-Affolter F, Bürgisser P, et al, and the Data Center of the Swiss HIV Cohort Study, Lausanne, Switzerland. Hepatitis E Virus seroprevalence and chronic infections in patients with HIV, Switzerland. Emerg Infect Dis 2011; 17: 1074-78.
104. Péron JM, Mansuy JM, Récher C, et al. Prolonged hepatitis E in an immunocompromised patient. J Gastroenterol Hepatol 2006; 21: 1223-24.
105. Tamura A, Shimizu YK, Tanaka T, et al. Persistent infection of hepatitis E virus transmitted by blood transfusion in a patient with T-cell lymphoma. Hepatol Res 2007; 37: 113-20. (Pubitemid 46403826)
106. Alric L, Bonnet D, Laurent G, Kamar N, Izopet J. Chronic hepatitis E virus infection: successful virologic response to pegylated interferon-alpha therapy. Ann Intern Med 2010; 153: 135-36.
107. Legrand-Abravanel F, Kamar N, Sandres-Saune K, et al. Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France. J Infect Dis 2010; 202: 835-44.
108. Schlosser B, Stein A, Neuhaus R, et al. Liver transplant from a donor with occult HEV infection induced chronic hepatitis and cirrhosis in the recipient. J Hepatol 2012; 56: 500-02.
109. le Coutre P, Meisel H, Hofmann J, et al. Reactivation of hepatitis E infection in a patient with acute lymphoblastic leukaemia after allogeneic stem cell transplantation. Gut 2009; 58: 699-702.
110. Kamar N, Abravanel F, Selves J, et al. Influence of immunosuppressive therapy on the natural history of genotype 3 hepatitis-E virus infection after organ transplantation. Transplantation 2010; 89: 353-60.
111. Renou C, Lafeuillade A, Cadranel JF, et al, and the ANGH. Hepatitis E virus in HIV-infected patients. AIDS 2010; 24: 1493-99.
112. Keane F, Gompels M, Bendall R, et al. Hepatitis E virus coinfection in patients with HIV infection. HIV Med 2012; 13: 83-88.
113. Kaba M, Richet H, Ravaux I, et al. Hepatitis E virus infection in patients infected with the human immunodeficiency virus. J Med Virol 2011; 83: 1704-16.
114. Thoden J, Venhoff N, Miehle N, et al. Hepatitis E and jaundice in an HIV-positive pregnant woman. AIDS 2008; 22: 909-10. (Pubitemid 351563846)
115. Colson P, Dhiver C, Poizot-Martin I, Tamalet C, Gérolami R. Acute and chronic hepatitis E in patients infected with human immunodeficiency virus. J Viral Hepat 2011; 18: 227-28.
116. Sood A, Midha V, Sood N. Guillain-Barrésyndrome with acute hepatitis E. Am J Gastroenterol 2000; 95: 3667-68.
117. Dixit VK, Abhilash VB, Kate MP, Jain AK. Hepatitis E infection with Bell's palsy. J Assoc Physicians India 2006; 54: 418.
118. Fong F, Illahi M. Neuralgic amyotrophy associated with hepatitis E virus. Clin Neurol Neurosurg 2009; 111: 193-95.
119. Mandal K, Chopra N. Acute transverse myelitis following hepatitis E virus infection. Indian Pediatr 2006; 43: 365-66.
120. Kejariwal D, Roy S, Sarkar N. Seizure associated with acute hepatitis E. Neurology 2001; 57: 1935. (Pubitemid 33096721)
121. Kamar N, Bendall RP, Peron JM, et al. Hepatitis E virus and neurologic disorders. Emerg Infect Dis 2011; 17: 173-79.
122. Kamar N, Izopet J, Cintas P, et al. Hepatitis E virus-induced neurological symptoms in a kidney-transplant patient with chronic hepatitis. Am J Transplant 2010; 10: 1321-24.
123. Maurissen I, Jeurissen A, Strauven T, Sprengers D, De Schepper B. First case of anti-ganglioside GM1-positive Guillain-Barre syndrome due to hepatitis E virus infection. Infection 2011; published online April 10. DOI:10.1007/s15010-011-0185-6.
124. Despierres LA, Kaphan E, Attarian S, et al. Neurologic disorders and hepatitis E, France, 2010. Emerg Infect Dis 2011; 17: 1510-12.
125. Ali G, Kumar M, Bali S, Wadhwa W. Heptitis E associated immune thrombocytopenia and membranous glomerulonephritis. Indian J Nephrol 2001; 11: 70-72.
126. Deniel C, Coton T, Brardjanian S, Guisset M, Nicand E, Simon F. Acute pancreatitis: a rare complication of acute hepatitis E. J Clin Virol 2011; 51: 202-04.
127. Fourquet E, Mansuy JM, Bureau C, et al. Severe thrombocytopenia associated with acute autochthonous hepatitis E. J Clin Virol 2010; 48: 73-74.
128. Péron JM, Dalton H, Izopet J, Kamar N. Acute autochthonous hepatitis E in western patients with underlying chronic liver disease: a role for ribavirin? J Hepatol 2011; 54: 1323-24, author reply 1324-25.
129. Gerolami R, Borentain P, Raissouni F, Motte A, Solas C, Colson P. Treatment of severe acute hepatitis E by ribavirin. J Clin Virol 2011; 52: 60-62.
130. Kamar N, Rostaing L, Abravanel F, et al. Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation. Clin Infect Dis 2010; 50: e30-33.
131. Haagsma EB, Riezebos-Brilman A, van den Berg AP, Porte RJ, Niesters HG. Treatment of chronic hepatitis E in liver transplant recipients with pegylated interferon alpha-2b. Liver Transpl 2010; 16: 474-77.
132. Mallet V, Nicand E, Sultanik P, et al. Brief communication: case reports of ribavirin treatment for chronic hepatitis E. Ann Intern Med 2010; 153: 85-89.
133. Dalton HR, Keane FE, Bendall R, Mathew J, Ijaz S. Treatment of chronic hepatitis E in a patient with HIV infection. Ann Intern Med 2011; 155: 479-80.
134. Alric L, Bonnet D, Beynes-Rauzy O, Izopet J, Kamar N. Definitive clearance of a chronic hepatitis E virus infection with ribavirin treatment. Am J Gastroenterol 2011; 106: 1562-63.
135. Colson P, Coze C, Gallian P, Henry M, De Micco P, Tamalet C. Transfusion-associated hepatitis E, France. Emerg Infect Dis 2007; 13: 648-49.
136. Matsubayashi K, Nagaoka Y, Sakata H, et al. Transfusiontransmitted hepatitis E caused by apparently indigenous hepatitis E virus strain in Hokkaido, Japan. Transfusion 2004; 44: 934-40. (Pubitemid 38738426)
137. Boxall E, Herborn A, Kochethu G, et al. Transfusion-transmitted hepatitis E in a 'nonhyperendemic' country. Transfus Med 2006; 16: 79-83. (Pubitemid 43935063)
138. Ijaz S, Szypulska R, Tettmar KI, Kitchen A, Tedder RS. Detection of hepatitis E virus RNA in plasma mini-pools from blood donors in England. Vox Sang 2011; published online Sept 30. DOI:10.1111/j.1423-0410.2011.01554.x.
139. Guo QS, Yan Q, Xiong JH, et al. Prevalence of hepatitis E virus in Chinese blood donors. J Clin Microbiol 2010; 48: 317-18.
140. Li SW, Zhang J, Li YM, et al. A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates. Vaccine 2005; 23: 2893-901. (Pubitemid 40386491)
141. Zhang J, Liu CB, Li RC, et al. Randomized-controlled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccine. Vaccine 2009; 27: 1869-74.